Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125747133 | 12574713 | 3 | F | 20160721 | 20160720 | 20160801 | EXP | US-PFIZER INC-2016346768 | PFIZER | WOODS, R.. CLINICAL MANAGEMENT OF RESISTANCE EVOLUTION IN A BACTERIAL INFECTION: A CASE STUDY. EVOLUTION, MEDICINE AND PUBLIC HEALTH. 2015;2015 (1):281-288 | 56.00 | YR | F | Y | 0.00000 | 20160801 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125747133 | 12574713 | 1 | PS | CEFEPIME HCL | CEFEPIME HYDROCHLORIDE | 1 | UNK | 50679 | |||||||||||
125747133 | 12574713 | 2 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | UNK | U | 77245 | ||||||||||
125747133 | 12574713 | 3 | SS | CLINDAMYCIN HCL | CLINDAMYCIN HYDROCHLORIDE | 1 | Oral | UNK | U | 50162 | CAPSULE, HARD | ||||||||
125747133 | 12574713 | 4 | SS | CLINDAMYCIN HCL | CLINDAMYCIN HYDROCHLORIDE | 1 | U | 50162 | CAPSULE, HARD | ||||||||||
125747133 | 12574713 | 5 | SS | DAPTOMYCIN. | DAPTOMYCIN | 1 | UNK | U | 202857 | POWDER FOR INJECTION | |||||||||
125747133 | 12574713 | 6 | SS | MEROPENEM. | MEROPENEM | 1 | UNK | U | 90940 | ||||||||||
125747133 | 12574713 | 7 | SS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | UNK | 62911 | |||||||||||
125747133 | 12574713 | 8 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | UNK | U | 0 | ||||||||||
125747133 | 12574713 | 9 | SS | MOXIFLOXACIN. | MOXIFLOXACIN | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125747133 | 12574713 | 1 | Bacterial infection |
125747133 | 12574713 | 2 | Bacterial infection |
125747133 | 12574713 | 3 | Bacterial infection |
125747133 | 12574713 | 4 | Staphylococcal infection |
125747133 | 12574713 | 5 | Bacterial infection |
125747133 | 12574713 | 6 | Bacterial infection |
125747133 | 12574713 | 7 | Bacterial infection |
125747133 | 12574713 | 8 | Bacterial infection |
125747133 | 12574713 | 9 | Bacterial infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125747133 | 12574713 | DE |
125747133 | 12574713 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125747133 | 12574713 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |